Clinical Trial Update: Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell Granuloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating calcitonin nasal spray for reducing recurrence of aggressive Central Giant Cell Granuloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Giant Cell Granuloma

Drugs mentioned

• Calcitonin nasal spray (calcitonin)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Central Giant Cell Granuloma | Phase 2 | Status: COMPLETED